-
IMF: The Innovative Medicines Fund or the Interim Medicines Fund?
Sep 9, 2025, 16:22 PM -
Use of a Nonparametric Bayesian Method to Model Health State Preferences: An Application to UAE EQ-5D-5L Valuations
Sep 9, 2025, 16:22 PM -
Real-World Evidence From Community Oncology: Assessing Secular Trends in Ovarian Cancer Diagnoses From 2014 to 2024
Sep 9, 2025, 16:22 PM -
A Comparison of Methods for Missing Covariates in a Meta-Regression Using Data From a Systematic Review on Oral Epithelial Dysplasia
Sep 9, 2025, 16:22 PM -
Assessment of the Economic and Societal Impact of Cervical Cancer Treatment in Bulgaria
Sep 9, 2025, 16:22 PM -
Signal Detection and Network Pharmacology Analysis of Paronychia Associated With eGFR Inhibitors
Sep 9, 2025, 16:22 PM -
Simulated Treatment Comparisons Using Jackknife Pseudo Values for Population-Adjusted Marginal Effect Estimation
Sep 9, 2025, 16:22 PM -
The Incidence Mortality and Survival of Malignant Hematopoietic Neoplasms in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2000-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
The Disease Burden of Respiratory Syncytial Virus Among the Adult Population in Greece
Sep 9, 2025, 16:22 PM -
Do We Need to Measure Social Impact of Innovative Drugs?
Sep 9, 2025, 16:22 PM -
Development of a Unique Tool for Assessing the Feasibility of an External Control Arm Study
Sep 9, 2025, 16:22 PM -
Experience of Pediatric Dental Screening in Hungary and in National Minority Groups in Romania
Sep 9, 2025, 16:22 PM -
The Role of a Functional Clinical Staff in Guiding High-Cost Drug and Novel Technology Decision Making: Experience From a Latin American Oncology Clinic
Sep 9, 2025, 16:22 PM -
Pragmatic Advice to Improve Assessment Schedule of Preference-Based Measures of Health to Estimate Utilities in Clinical Trials
Sep 9, 2025, 16:22 PM -
Challenges in the German AMNOG Procedure: The Need for National PICO Transparency and Optimized Consultation Windows in the Context of EU-HTA
Sep 9, 2025, 16:22 PM -
The Incidence, Mortality, and Survival of Nonmetastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Global Access to Innovative Medicines in 2025: Europe’s Gaps and the UK’s Continued Decline
Sep 9, 2025, 16:22 PM -
Canadian HTA Decisions (2020-2023): Comparing CDA-AMC and INESSS Recommendations on Drug Reimbursement
Sep 9, 2025, 16:22 PM -
Zero-Shot RCT Identification Using Large Language Models: A Comparative Study With the Cochrane Classifier
Sep 9, 2025, 16:22 PM -
Economic Evaluations of Medical Interventions for Adult People Living With Obesity: Protocol for a Systematic Literature Review
Sep 9, 2025, 16:22 PM
